Tag: Drug approval

news-14062024-132127

FDA panel rejects MDMA-assisted therapies for PTSD veterans’ hopes dashed.New Title: FDA Panel...

The recent decision by a U.S. Food and Drug Administration (FDA) panel to reject MDMA-based treatments for post-traumatic stress disorder (PTSD) has left many...
chinas-nmpa-accepts-bla-for-zanidatamab-in-her2-biliary-tract-cancer

China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract Cancer

China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract CancerThe National Medical Products Administration (NMPA) in China has approved the biologics license application...

BREAKING NEWS